¼¼°èÀÇ Ä¿³ØÆ¼µå ¾à¹°Àü´Þ µð¹ÙÀ̽º ½ÃÀå º¸°í¼­(2025³â)
Connected Drug Delivery Devices Global Market Report 2025
»óǰÄÚµå : 1682153
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 200 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,496,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 9,390,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 12,284,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

Ä¿³ØÆ¼µå ¾à¹°Àü´Þ µð¹ÙÀ̽º ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¼ö³â°£ ºñ¾àÀûÀÎ ¼ºÀåÀ» ÀÌ·ê °ÍÀ¸·Î Àü¸ÁµË´Ï´Ù. ¿¹Ãø ±â°£ÀÇ ¼ºÀåÀº ¸¸¼º ÁúȯÀÇ À¯º´·ü Áõ°¡, ó¹æµÈ Ä¡·á¹ý Áؼö¿¡ ´ëÇÑ È¯ÀÚÀÇ ÀÇ½Ä Áõ°¡, ±Þ¼ÓÈ÷ ÁøÇàµÇ´Â °Ç°­ °ü¸® IT ÀÎÇÁ¶ó, ¿¹¹æ ÀÇ·áÀÇ Á߽à Áõ°¡, ÀüÀÚ ÀÇ·á ±â·Ï(EHR)À» °ü¸®Çϱâ À§ÇÑ °Ë»ç½ÇÀ̳ª º´¿ø¿¡¼­ÀÇ Ä¿³ØÆ¼µå µð¹ÙÀ̽ºÀÇ ±¤¹üÀ§ÇÑ Ã¤¿ë µî¿¡ ±âÀÎÇÑ´Ù°í »ý°¢µË´Ï´Ù.

Ä¿³ØÆ¼µå ¾à¹°Àü´Þ ½ÃÀåÀÇ ¼ºÀåÀº ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ(RPM)ÀÇ Á߿伺ÀÌ ³ô¾ÆÁüÀ¸·Î½á ¿¹ÃøµÉ ¼ö ÀÖ½À´Ï´Ù. Ä¿³ØÆ¼µå ¾à¹° Àü´Þ ÀåÄ¡´Â ¾à¹° »ç¿ë·®°ú ¼øÀÀµµ¸¦ Á¤È®ÇÏ°Ô ÃßÀûÇϰí Àû½Ã¿¡ °³ÀÔÇÏ¸ç °³ÀÎÈ­µÈ Ä¡·á °ü¸®¸¦ Á¦°øÇÔÀ¸·Î½á RPMÀ» Çâ»ó½ÃŰ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ¿¹¸¦ µé¾î, 2023³â 8¿ù ¹Ì±¹ÀÇ µðÁöÅÐ ÀÇ·á ¼Ö·ç¼Ç Á¦°ø¾÷üÀÎ Vivalink°¡ ½Ç½ÃÇÑ ¼³¹®Á¶»ç¿¡ µû¸£¸é ȯÀÚ¿¡°Ô RPMÀ» Ȱ¿ëÇÏ´Â ÀÓ»óÀǰ¡ 2021³â 20%¿¡¼­ 81%·Î 305% Å©°Ô Áõ°¡ÇßÀ¸¸ç, À̵é Áß 84%°¡ 2024³â¿¡ RPM »ç¿ëÀ» È®´ëÇß½À´Ï´Ù.

Ä¿³ØÆ¼µå ¾à¹°Àü´Þ µð¹ÙÀ̽º ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷Àº ½ÃÀåÀÇ ¼öÀͼºÀ» ³ôÀ̱â À§ÇØ µðÁöÅРȣÈí±â °Ç°­ ¼Ö·ç¼Ç°ú °°Àº Çõ½ÅÀûÀÎ ±â¼ú °³¹ß¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. ¿¬°áµÈ ¾à¹° Àü´Þ ÀåÄ¡¸¦ À§ÇÑ µðÁöÅРȣÈí±â °Ç°­ ¼Ö·ç¼ÇÀº È£Èí±â¿¡ ¾à¹°À» Àü´ÞÇÏ´Â µ¿½Ã¿¡ »ç¿ë·®°ú °Ç°­ µ¥ÀÌÅ͸¦ ¸ð´ÏÅ͸µÇÏ¿© ȯÀÚ °á°ú¸¦ °³¼±ÇÏ´Â ±â¼ú Áö¿ø ÀåÄ¡¸¦ Æ÷ÇÔÇÕ´Ï´Ù. ¿¹¸¦ µé¾î, 2022³â 2¿ù, ¹Ì±¹¿¡ º»»ç¸¦ µÐ Á¶Á¦ Æ÷Àå ¹× ¾à¹°Àü´Þ µð¹ÙÀ̽º Á¦Á¶¾÷üÀÎ AptarGroup Inc.´Â HeroTracker Sense¸¦ µµÀÔÇß½À´Ï´Ù. ÀÌ Çõ½ÅÀûÀÎ µðÁöÅÐ µµ±¸´Â ±âÁ¸ÀÇ Á¤·® ºÐ¹«½Ä ÈíÀԱ⸦ ½º¸¶Æ® ¿¬°á ÀåÄ¡·Î ÀüȯÇÏ¿© õ½Ä°ú COPD¿Í °°Àº ¸¸¼º È£Èí±â Áúȯ ȯÀÚÀÇ º¹¾à Ãæ°Ý°ú °ü¸®¸¦ °­È­ÇÕ´Ï´Ù. ºÐ¼® ¹× ÀλçÀÌÆ®¸¦ À§ÇÑ ¼¾¼­¿Í °°Àº ±â´ÉÀ» ÅëÇÕÇÏ¿© BreatheSmart ¾ÛÀ» ÅëÇÑ È¯ÀÚ ¼øÀÀµµ ¸ð´ÏÅ͸µÀ» Áö¿øÇÔÀ¸·Î½á È£Èí±â ÁúȯÀ» È¿°úÀûÀ¸·Î °ü¸®ÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå - ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, Äڷγª ¹× ȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°/±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ ÇÁ·ÎÆÄÀÏ

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷ ¹× Çõ½Å ±â¾÷

Á¦32Àå ¼¼°è ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´(M&A)

Á¦34Àå ÃÖ±Ù ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀåÀÇ ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

KTH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Connected drug delivery devices are advanced pharmaceutical tools that employ digital technology to monitor, regulate, and oversee the dispensing of medications, thereby improving adherence and patient outcomes. These devices are capable of internet connectivity, enabling data exchange between patients and healthcare providers to monitor medication usage, adjust dosages, and enhance treatment strategies.

The primary categories of connected drug delivery devices encompass standalone components, software, and integrated devices. Standalone components and software denote software or hardware capable of functioning independently or separately from a medical device that generates or utilizes it. They leverage various technologies such as Bluetooth, near-field communication (NFC), and others. These devices cater to a range of routes of administration including parenteral and inhalational methods, and find applications in conditions like asthma, chronic obstructive pulmonary disease, diabetes management, among others.

The connected drug delivery devices market research report is one of a series of new reports from The Business Research Company that provides connected drug delivery devices market statistics, including connected drug delivery devices industry global market size, regional shares, competitors with a connected drug delivery devices market share, detailed connected drug delivery devices market segments, market trends and opportunities, and any further data you may need to thrive in the connected drug delivery devices industry. This connected drug delivery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The connected drug delivery devices market size has grown exponentially in recent years. It will grow from $7.48 billion in 2024 to $9.29 billion in 2025 at a compound annual growth rate (CAGR) of 24.2%. The growth in the historic period can be attributed to increased awareness of connected devices, increased importance of remote monitoring for medication adherence, increased patient engagement, widespread consumer adoption, the rapidly increasing cost of medical management.

The connected drug delivery devices market size is expected to see exponential growth in the next few years. It will grow to $21.92 billion in 2029 at a compound annual growth rate (CAGR) of 23.9%. The growth in the forecast period can be attributed to increasing prevalence of chronic diseases, rising patient awareness about adherence to prescribed therapies, rapidly moving healthcare it infrastructure, increasing emphasis on preventive care, widespread adoption of connected devices in laboratories and hospitals for maintaining electronic health records (EHR). Major trends in the forecast period include increasing R&D activities, surge in technological innovation and the increasing connectivity of devices, soaring adoption of machine learning and artificial intelligence, rising implementation of telehealth platform integrated with AR/VR technologies, increasing adoption of electronic technology in healthcare devices.

The growth of the connected drug delivery device market is anticipated to be propelled by the increasing significance of remote patient monitoring (RPM). Remote patient monitoring is a healthcare delivery method utilizing technology to monitor patient health and medical data from a distance. Connected drug delivery devices play a crucial role in enhancing RPM by enabling precise tracking of medication usage and adherence, facilitating timely interventions, and offering personalized care management. For example, a survey conducted by Vivalink Inc., a US-based digital health solutions provider, in August 2023, revealed a significant increase of 305% in clinicians utilizing RPM on patients, rising from 20% in 2021 to 81% presently, with 84% of these users planning to expand their RPM usage in 2024. Consequently, the growing importance of remote patient monitoring is propelling the growth of the connected drug delivery device market.

Major players in the connected drug delivery devices market are concentrating on developing innovative technologies, such as digital respiratory health solutions, to enhance their market profitability. Digital respiratory health solutions for connected drug delivery devices encompass technology-enabled devices facilitating medication delivery to the respiratory system while monitoring usage and health data to improve patient outcomes. For instance, in February 2022, AptarGroup Inc., a US-based manufacturer of dispensing packaging and drug delivery devices, introduced HeroTracker Sense. This innovative digital tool transforms traditional metered-dose inhalers into smart, connected devices, enhancing medication adherence and management for individuals with chronic respiratory conditions like asthma and COPD. It incorporates features such as sensors for analytics and insights, supporting patient adherence monitoring via the BreatheSmart app, thereby aiding in the effective management of respiratory diseases.

In May 2022, Halozyme Therapeutics Inc., a US-based biopharmaceutical company, acquired Antares Pharma Inc. for an undisclosed sum. This acquisition is expected to bolster Halozyme's strategy, solidify its position as a top drug delivery firm, and expand its coverage of specialized products with its best-in-class auto-injector technology and specialty commercial business. Antares Pharma Inc. is a US-based specialty pharmaceutical company operating in the connected drug delivery sector.

Major players in the connected drug delivery devices market are Pfizer Inc., Johnson & Johnson, Bayer AG, AstraZeneca PLC, Abbott Laboratories, Novartis AG, Medtronic PLC, Eli Lilly and Company, Amgen Inc., Boehringer Ingelheim International GmbH, Novo Nordisk A/S, Merck Group, Becton Dickinson and Company, GlaxoSmithKline PLC, Phillips-Medisize Corporation, AptarGroup Inc., Dexcom Inc., West Pharmaceutical Services Inc., Insulet Corporation, OPKO Health Inc., Tandem Diabetes Care Inc., Ypsomed AG, Meridian Medical Technologies LLC, Propeller Health, and Findair Sp. z.o.o.

North America was the largest region in the connected drug delivery market in 2024. The regions covered in connected drug delivery device report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the connected drug delivery device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The connected drug delivery device market consists of revenues earned by entities by providing services such as medication reminders and alerts, dose tracking, data sharing, adjustable dosing, and integration with health records. The market value includes the value of related goods sold by the service provider or included within the service offering. The connected drug delivery device market also includes sales of smart inhalers, connected insulin pumps, smart pill dispensers, wearable drug delivery devices, and digital pills that are used in providing services. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Connected Drug Delivery Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on connected drug delivery devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for connected drug delivery devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The connected drug delivery devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Connected Drug Delivery Devices Market Characteristics

3. Connected Drug Delivery Devices Market Trends And Strategies

4. Connected Drug Delivery Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Connected Drug Delivery Devices Growth Analysis And Strategic Analysis Framework

6. Connected Drug Delivery Devices Market Segmentation

7. Connected Drug Delivery Devices Market Regional And Country Analysis

8. Asia-Pacific Connected Drug Delivery Devices Market

9. China Connected Drug Delivery Devices Market

10. India Connected Drug Delivery Devices Market

11. Japan Connected Drug Delivery Devices Market

12. Australia Connected Drug Delivery Devices Market

13. Indonesia Connected Drug Delivery Devices Market

14. South Korea Connected Drug Delivery Devices Market

15. Western Europe Connected Drug Delivery Devices Market

16. UK Connected Drug Delivery Devices Market

17. Germany Connected Drug Delivery Devices Market

18. France Connected Drug Delivery Devices Market

19. Italy Connected Drug Delivery Devices Market

20. Spain Connected Drug Delivery Devices Market

21. Eastern Europe Connected Drug Delivery Devices Market

22. Russia Connected Drug Delivery Devices Market

23. North America Connected Drug Delivery Devices Market

24. USA Connected Drug Delivery Devices Market

25. Canada Connected Drug Delivery Devices Market

26. South America Connected Drug Delivery Devices Market

27. Brazil Connected Drug Delivery Devices Market

28. Middle East Connected Drug Delivery Devices Market

29. Africa Connected Drug Delivery Devices Market

30. Connected Drug Delivery Devices Market Competitive Landscape And Company Profiles

31. Connected Drug Delivery Devices Market Other Major And Innovative Companies

32. Global Connected Drug Delivery Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Connected Drug Delivery Devices Market

34. Recent Developments In The Connected Drug Delivery Devices Market

35. Connected Drug Delivery Devices Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â